Verastem, Inc. (VSTM)

Oncology Corporate Profile

Stock Performance

1.6800
-0.0200

HQ Location

215 First Street, Suite 440
Cambridge, MA 2142

Company Description

Verastem, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation.

Website: http://www.verastem.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
duvelisibP13K inhibitorChronic Lymphocytic Leukemia (CLL)III
defactinibP13K inhibitorChronic Lymphocytic Leukemia (CLL)II
defactinib (+ pembrolizumab)P13K inhibitorMesotheliomaIIMerck
defactinib (+ pembrolizumab)P13K inhibitorNon Small Cell Lung Cancer (NSCLC)IIMerck
duvelisibP13K inhibitorNon-Hodgkin's Lymphoma (NHL)II
defactinib (+ avelumab)P13K inhibitorOvarian cancerIIPfizer and Merck
defactinib (+ pembrolizumab)P13K inhibitorPancreatic cancerIIMerck
defactinib (+ pembrolizumab and gemcitabine)P13K inhibitorPancreatic cancerIMerck
duvelisibP13K inhibitorRefractory T-cell LymphomaI
VS-5584mTORC1/2 inhibitorLymphomaPreclinical
VS-4718 (+ abraxane)FAK/PYK2 inhibitorPancreatic cancerPreclinical
VS-4718 (+ abraxane)FAK/PYK2 inhibitorVarious cancer typesPreclinical
VS-5584mTORC1/2 inhibitorVarious cancer typesPreclinical

Source: http://www.verastem.com

Recent News Headlines

6/26/2017 06:20 am

6/26/2017 06:20 am

6/26/2017 06:20 am

6/26/2017 06:20 am

6/26/2017 06:20 am

6/24/2017 06:20 am

6/24/2017 06:20 am

6/24/2017 06:20 am

6/24/2017 06:20 am

6/24/2017 06:20 am

6/7/2017 12:19 pm

6/7/2017 12:19 pm

6/7/2017 12:19 pm

6/7/2017 12:19 pm

6/5/2017 12:20 pm

6/5/2017 12:20 pm

6/5/2017 12:20 pm

6/5/2017 12:20 pm

5/10/2017 12:19 pm

5/10/2017 06:19 am

5/3/2017 12:19 am

5/2/2017 12:19 am

4/17/2017 06:19 am

4/9/2017 12:17 am

Verastem to Present at the 16th Annual Needham Healthcare Conference

4/3/2017 11:00 am

[Business Wire] - Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the 16th Annual Needham Healthcare Conference on Tuesday, April 4th at 3:00 p.m.